IBLHL Stock Overview
Engages in marketing, selling, and distribution of healthcare and pharmaceutical products in Pakistan. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
IBL HealthCare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | PK₨39.49 |
| 52 Week High | PK₨46.17 |
| 52 Week Low | PK₨25.80 |
| Beta | 1.25 |
| 11 Month Change | 34.18% |
| 3 Month Change | 24.07% |
| 1 Year Change | 8.22% |
| 33 Year Change | -29.84% |
| 5 Year Change | 13.52% |
| Change since IPO | 603.07% |
Recent News & Updates
Recent updates
Shareholder Returns
| IBLHL | PK Healthcare | PK Market | |
|---|---|---|---|
| 7D | -8.4% | -0.5% | 2.5% |
| 1Y | 8.2% | -3.4% | 44.0% |
Return vs Industry: IBLHL exceeded the PK Healthcare industry which returned -3.4% over the past year.
Return vs Market: IBLHL underperformed the PK Market which returned 44% over the past year.
Price Volatility
| IBLHL volatility | |
|---|---|
| IBLHL Average Weekly Movement | 7.1% |
| Healthcare Industry Average Movement | 5.2% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in PK Market | 9.6% |
| 10% least volatile stocks in PK Market | 3.9% |
Stable Share Price: IBLHL has not had significant price volatility in the past 3 months compared to the PK market.
Volatility Over Time: IBLHL's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 292 | Muhammad Ghiyasuddin | www.iblhc.com |
IBL HealthCare Limited engages in marketing, selling, and distribution of healthcare and pharmaceutical products in Pakistan. The company offers toddlers, baby cereals, infant formulas, medical and lifestyle nutrition, and speciality nutrition products; hygiene and safety products; consumer health products; and vision care and pharma products. It also provides renal care products, such as hollow fiber dialyzer, tubing sets for hemodialysis, double lumen catheter kits, and disposable AV fistula needles; critical care and anesthesia products, such as meditech connectors, circuits, filters, anesthesia masks, and oxygen therapy products; surgical and examination gloves; pharmaceuticals; blood transfusion sets and blood bags; IV administration products; and surgical tape, urine collection bags with T-connector, oxygen face; and nebulizer masks, nasal oxygen cannula, infant feeding tubes, and suction catheter.
IBL HealthCare Limited Fundamentals Summary
| IBLHL fundamental statistics | |
|---|---|
| Market cap | PK₨3.38b |
| Earnings (TTM) | -PK₨12.49m |
| Revenue (TTM) | PK₨3.62b |
0.9x
P/S Ratio-270.8x
P/E RatioIs IBLHL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IBLHL income statement (TTM) | |
|---|---|
| Revenue | PK₨3.62b |
| Cost of Revenue | PK₨2.69b |
| Gross Profit | PK₨935.84m |
| Other Expenses | PK₨948.33m |
| Earnings | -PK₨12.49m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.15 |
| Gross Margin | 25.84% |
| Net Profit Margin | -0.34% |
| Debt/Equity Ratio | 19.2% |
How did IBLHL perform over the long term?
See historical performance and comparison